Background Introduction

Neutralizing antibodies play a vital role in COVID-19 detection, R&D on and antibody drug. Neutralizing antibody detection is the top priority to accelerate the global anti-epidemic process! The kit produced with COVID-19 neutralizing antibody raw material developed by Qingdao Henderson Biotechnology Co., Ltd has passed the EU CE certification with substantial sales volume and sound feedback in overseas market. 

Recommended Diagnostic Raw Materials

[Product Information] 

[Product Advantages]  

★ Good affinity, high sensitivity and specificity!

★ Good comparison correlation in cell neutralization test!

★The products of existing manufacturers have obtained CE certificates for market application.

★Capacity of spot supplies in large quantity

[Product Performance]

On the enzyme-linked immunosorbent platform, the neutralizing antibody pairing raw material kit was compared with the products of excellent manufacturers in bio-industry in China to detect four quality control products, and the agreement rate turned to be 100%.

On the chemiluminescence platform, chemiluminescence reagents paired monoclonal antibody were used to detect the serum assigned by R company renowned internationally, and the sample agreement rate was R2 >98%.

On the enzyme-linked immunosorbent platform, the neutralizing antibody pairing material kit was compared with the first kit in China that obtained EUA certification, and clinical samples were tested with an agreement rate of 96%.

[Company Background]

Qingdao Henderson Biotechnology Co., Ltd, established in 2016, serves as a professional supplier of core raw materials for in vitro diagnostic reagents and is committed to providing high-quality raw materials for global in vitro diagnostic reagent production enterprises, scientific research institutions and other fields.

The company provides the following staple products: antigens, antibodies, enzymes, etc., widely used in the detection of drug, respiratory infectious diseases (A, B, COVID-19 antigen, COVID-19 antibody, COVID-19 neutralizing antibody, syncytial virus, etc.), other infectious diseases (hepatitis, AIDS, tuberculosis, etc.), markers for tumor, inflammation, myocardial markers, animal diseases detection (dog, cat diseases) and other fields. 

The company, after years of development, has established several specialized laboratories and SPF experimental animal bases, a comprehensive and systematic R&D verification platform and formed a professional technical service team to provide personalized customized services and one-stop solutions.

Qingdao Henderson Biotechnology Co., Ltd is willing to build a renowned product brand for all customers with high-quality products and professional services to keep a foothold in the market with its sound competitiveness.

Limited space only allows the introduction of major products. You are welcomed to contact Qingdao Henderson Biotechnology Co., Ltd and acquire trial samples if you need more information.

Qingdao Henderson Biotechnology Co., Ltd.

Official Website: http://www.qdhenderson.com/

Tel: 0532-84670782

E-mail: info@qdhenderson.com